Indications:
- Used in combination with prednisone or prednisolone for the treatment of metastatic castration-resistant prostate cancer (mCRPC) in adult men.
-
May be prescribed in earlier stages of advanced prostate cancer alongside androgen deprivation therapy.
Administration:
- The recommended dose is usually 1,000mg once daily (taken as four 250mg tablets) together with prednisone/prednisolone or as directed by a healthcare provider.
- Tablets should be swallowed whole with water, on an empty stomach (at least 1 hour before or 2 hours after food).
-
Always follow the exact dosing instructions given by your oncologist.
Safety Information:
- Do not use if you are allergic to abiraterone or any of its ingredients.
- Inform your doctor if you have liver problems, heart disease, high blood pressure, or low blood potassium levels.
- Regular blood tests are required to monitor liver function, potassium levels, and blood pressure during treatment.
- Common side effects may include: fluid retention, high blood pressure, liver enzyme changes, joint swelling, and fatigue.
-
Serious side effects such as liver toxicity, arrhythmias, or adrenal problems may occur and require urgent medical attention
Notice:
Abiraterone Tablets 250mg are a prescription-only medicine and should be used strictly under the supervision of a qualified oncologist or healthcare provider.
Reviews
There are no reviews yet.